1. Home
  2. MNKD vs COUR Comparison

MNKD vs COUR Comparison

Compare MNKD & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • COUR
  • Stock Information
  • Founded
  • MNKD 1991
  • COUR 2012
  • Country
  • MNKD United States
  • COUR United States
  • Employees
  • MNKD N/A
  • COUR 1260
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • COUR Computer Software: Prepackaged Software
  • Sector
  • MNKD Health Care
  • COUR Technology
  • Exchange
  • MNKD Nasdaq
  • COUR Nasdaq
  • Market Cap
  • MNKD 1.4B
  • COUR 1.4B
  • IPO Year
  • MNKD 2004
  • COUR 2021
  • Fundamental
  • Price
  • MNKD $4.15
  • COUR $8.85
  • Analyst Decision
  • MNKD Strong Buy
  • COUR Buy
  • Analyst Count
  • MNKD 5
  • COUR 13
  • Target Price
  • MNKD $9.40
  • COUR $10.29
  • AVG Volume (30 Days)
  • MNKD 1.9M
  • COUR 1.8M
  • Earning Date
  • MNKD 05-08-2025
  • COUR 07-24-2025
  • Dividend Yield
  • MNKD N/A
  • COUR N/A
  • EPS Growth
  • MNKD 228.27
  • COUR N/A
  • EPS
  • MNKD 0.10
  • COUR N/A
  • Revenue
  • MNKD $297,595,000.00
  • COUR $704,874,000.00
  • Revenue This Year
  • MNKD $14.36
  • COUR $6.70
  • Revenue Next Year
  • MNKD $13.36
  • COUR $4.88
  • P/E Ratio
  • MNKD $40.01
  • COUR N/A
  • Revenue Growth
  • MNKD 32.50
  • COUR 7.25
  • 52 Week Low
  • MNKD $4.05
  • COUR $5.76
  • 52 Week High
  • MNKD $7.63
  • COUR $11.74
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.04
  • COUR 59.97
  • Support Level
  • MNKD $4.07
  • COUR $8.85
  • Resistance Level
  • MNKD $4.25
  • COUR $9.14
  • Average True Range (ATR)
  • MNKD 0.16
  • COUR 0.25
  • MACD
  • MNKD -0.03
  • COUR -0.05
  • Stochastic Oscillator
  • MNKD 12.82
  • COUR 48.92

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: